Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P49137
UPID:
MAPK2_HUMAN
Alternative names:
-
Alternative UPACC:
P49137; Q5SY30; Q5SY41; Q8IYD6
Background:
MAP kinase-activated protein kinase 2 (MAPKAPK2) is a pivotal serine/threonine-protein kinase that plays a crucial role in various cellular processes, including stress response, cytokine production, and cell cycle control. It is activated by MAP kinase p38-alpha/MAPK14 upon stress, leading to the phosphorylation of numerous substrates involved in critical cellular functions.
Therapeutic significance:
Understanding the role of MAP kinase-activated protein kinase 2 could open doors to potential therapeutic strategies. Its involvement in key cellular processes such as the DNA damage response, cytokine production, and cell migration positions it as a promising target for drug discovery efforts aimed at treating diseases with underlying stress response and cell cycle control dysregulation.